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Synopsis: Expert consensus derived clinical decision rules (CDRs) are presented to guide imaging 
decisions for PE in pregnant and post-partum patients.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Pulmonary Embolism (PE) is a leading cause of death during pregnancy and the postpartum period.[1] 
Existing clinical decision rules (CDRs) to guide imaging decisions in PE include d-dimer testing, which has 
been shown to be unreliable in pregnancy.[2] Current guidelines consequently recommend that all 
pregnant or postpartum women with suspected PE should receive advanced diagnostic imaging.[3] 
However this non-selective approach results in very low rates of detected PE, risks radiation exposure 
and reaction to contrast media, is inconvenient for patients, and incurs costs for the health services.[2] 
The Diagnosis of Pulmonary Embolism in Pregnancy (DIPEP) study is a prospective cohort study including 
pregnant and postpartum women with diagnosed and suspected PE in the UK.[4] The aim of the current 
study was to develop expert CDRs to guide imaging decisions in PE for validation in the DIPEP dataset. 
Three expert clinical decision rules were developed, each with a contrasting focus: (1) balancing 
sensitivity and specificity (primary CDR) (2) optimising sensitivity and (3) optimising specificity. To reduce 
biases arising from the subjectivity of expert views, and maximise content and face validity a two stage 
consensus process, guided by best practice guidelines, was conducted.[5-7] Ethical approval was given 
by a University of Sheffield ethics committee. All participants provided written informed consent. 
In the first stage, a web based Delphi survey was conducted to identify candidate clinical predictors of 
PE. Purposive sampling was used to recruit a heterogeneous group of 20 experts. The open first round of 
the classical Delphi approach was replaced with a systematic literature review to identify possible PE 
predictors.[2] Participants were then asked to rate the predictive value of each variable on a 1 to 5 Likert 
scale and justify their opinion. In subsequent Delphi iterations, participants were provided with 
quantitative and qualitative results of the previous round, and a summary of their previous opinions.   
In the second stage, the Nominal Group Technique (NGT) was used to formulate the content and scope 
of the three expert clinical decision rules. A series of face-to-face meetings, including rating rounds and 
structured group discussions, were conducted with a consensus panel consisting of DIPEP co-
investigators, facilitated by an independent researcher experienced in the NGT. Moderately or strongly 
predictive variables identified during the Delphi survey were considered for inclusion.  
The systematic literature review identified 45 potential variables for evaluation in the Delphi Survey. 
Three Delphi rounds were then conducted before stability of opinion was evident. Twenty four variables 
felt to be moderately or strongly predictive of PE were carried forward for consideration in the NGT 
meetings. Consensus was subsequently achieved for inclusion of 13 predictors in the final CDRs, with 
variable weightings and cut-point differing according to the focus of individual rules.  The scope of the 
CDRs, including inclusion and exclusion criteria, were also confirmed. The final CDRs are presented in 
Table 1. The performance of these rules now requires testing in appropriate populations, such as the 
DIPEP sample, prior to any introduction into clinical practice.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Consensus Derived CDRs to Guide Advanced Imaging Decisions for Pulmonary Embolism in 
Pregnancy and the Post-partum Period 
The CDRs apply to pregnant or post-partum women presenting with symptoms that prompt consideration of 
pulmonary embolism (e.g. chest pain, shortness of breath). The rule does not apply if: critically ill and/or in need 
of resuscitation; a clear non-PE diagnosis is identified by clinical assessment, including ECG, chest x-ray and 
blood tests where appropriate (e.g. chest infection); or an uncommon, but powerful, VTE risk factor exists, e.g. 
thrombophilia, intravenous illicit drug misuse. 
   VARIABLE WEIGHTING§ 
INCLUDED VARIABLES:   
Primary 
CDR 
Sensitive 
CDR 
Specific 
CDR 
Haemoptysis   3 1 4 
Pleuritic chest pain   0 1 0 
Previous VTE   3 1 4 
Family history of VTE in first degree relative   0 1 0 
Hospital admission, surgery or significant injury within 90 days 
[excluding Normal vaginal delivery or caesarean section]  
  2 1 
1 
Obstetric complication*   1 1 0 
Active medical co-morbidities ?   2 1 1 
Post partum or third trimester   1 1 0 
ZĂŝƐĞĚD/ш ? ?   1 1 0 
Clinical symptoms or signs of DVT**   3 1 4 
Oxygen sats<94% on room air   3 1 3 
Tachycardia >100bpm (in 1st or second trimester, or post-
partum) / Tachycardia >110bpm (in third trimester) 
  2 1 
2 
Increased respiratory rate >24 b/m   2 1 2 
CDR CUT POINT: 3 1 4 
*Obstetric complications - Apply once if any of the following are present: Pre-eclampsia in current pregnancy. Assisted reproductive technology (antenatal only), 
multiple pregnancy, Caesarean section in labour, elective caesarean section, mid-cavity or rotational operative delivery, prolonged labour (> 24 hours), post-partum 
haemorrhage (> 1 litre or transfusion), preterm birth < 37+0 weeks in current pregnancy, stillbirth in current pregnancy, hyperemesis, Ovarian hyper-stimulation 
syndrome (first trimester only).  ?Active medical co-morbidities - Apply once if any of the following are present: cancer, heart failure; systemic lupus erythematosus, 
inflammatory polyarthropathy or inflammatory bowel disease; nephrotic syndrome; type I or type 2 diabetes mellitus with nephropathy; sickle cell disease. ** 
Patients presenting with symptoms and / or signs of DVT and suspicion of PE would initially undergo Duplex ultrasound of the leg(s). If positive patients would be 
treated for DVT and presumed PE. Negative leg imaging does not rule out DVT and these patients would still be considered higher risk for PE. §The scoring systems 
for the primary and specific rules allow the three rules to be presented alongside each other. In practice these scores can be simplified by removing zero scoring 
variables. 
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